4-甲基-3-异丙基苯胺 | 5266-84-2

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-甲基-3-异丙基苯胺
• 中文别名: 4-甲基-3-(1-甲基乙基)苯胺
• 英文名称: 2-Isopropyl-4-aminotoluol
• 英文别名: 4-Amino-2-isopropyl-toluol；4-Methyl-3-(1-methylethyl)benzenamine；4-methyl-3-propan-2-ylaniline
• CAS: 5266-84-2
• 化学式: C₁₀H₁₅N
• 分子量: 149.236
• InChiKey: SHCLWCGJHOMCRX-UHFFFAOYSA-N

物化性质

• 沸点：
  123 °C(Press: 15 Torr)
• 密度：
  0.9568 g/cm3

计算性质

• 辛醇/水分配系数(LogP)：
  2.7
• 重原子数：
  11
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.4
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2921499090

反应信息

• 作为反应物：
  描述：

  4-甲基-3-异丙基苯胺 在 吡啶 、 盐酸 、 PPA 、 汞 、 锌 作用下， 生成 4-Isopropyl-5-methyl-indan
  参考文献：
  名称：

  Munavalli,S.; Ourisson,G., Bulletin de la Societe Chimique de France, 1964, p. 3103 - 3112

  摘要：

  DOI：
• 作为产物：
  描述：

  alkaline earth salt of/the/ methylsulfuric acid 在 盐酸 、 铁粉 作用下， 生成 4-甲基-3-异丙基苯胺
  参考文献：
  名称：

  Desseigne, Bulletin de la Societe Chimique de France, 1935, vol. <5> 2, p. 617,618

  摘要：

  DOI：

文献信息

• COMPOUNDS TARGETING PROTEINS, COMPOSITIONS, METHODS, AND USES THEREOF
  申请人：BioTheryX, Inc.

  公开号：US20180170948A1

  公开（公告）日：2018-06-21

  The present invention provides compounds that modulate protein function, to restore protein homeostasis, including cytokine, CK1α, GSPT1, aiolos, and/or ikaros activity, and cell-cell adhesion. The invention provides methods of modulating protein-mediated diseases, such as cytokine-mediated diseases, disorders, conditions, or responses. Compositions, including in combination with other cytokine and inflammatory mediators, are provided. Methods of treatment, amelioration, or prevention of diseases, disorders, or conditions associated with a protein, such as diseases, disorders, and conditions associated with cytokines, including inflammation, fibromyalgia, rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, psoriasis, psoriatic arthritis, inflammatory bowel diseases, Crohn's disease, ulcerative colitis, uveitis, inflammatory lung diseases, chronic obstructive pulmonary disease, Alzheimer's disease, and cancer, are provided.

  本发明提供了调节蛋白功能的化合物，以恢复蛋白稳态，包括细胞因子、CK1α、GSPT1、艾奥洛斯和/或伊卡洛斯活性和细胞间粘附。该发明提供了一种调节蛋白介导的疾病的方法，如细胞因子介导的疾病、障碍、状况或反应。提供了包括与其他细胞因子和炎症介质结合的组合物。提供了治疗、改善或预防与蛋白相关的疾病、障碍或状况的方法，包括与细胞因子相关的疾病、障碍和状况，包括炎症、纤维肌痛、类风湿性关节炎、骨关节炎、强直性脊柱炎、银屑病、银屑病关节炎、炎症性肠病、克罗恩病、溃疡性结肠炎、葡萄膜炎、炎症性肺病、慢性阻塞性肺病、阿尔茨海默病和癌症。
• USE OF SUBSTITUTED ISOQUINOLINONES, ISOQUINOLINDIONES, ISOQUINOLINTRIONES AND DIHYDROISOQUINOLINONES OR IN EACH CASE SALTS THEREOF AS ACTIVE AGENTS AGAINST ABIOTIC STRESS IN PLANTS
  申请人：Frackenpohl Jens

  公开号：US20140302987A1

  公开（公告）日：2014-10-09

  Use of substituted isoquinolinones, isoquinolinediones, isoquinolinetriones and dihydroisoquinolinones of the general formula (I) or their respective salts where the radicals in the general formula (I) correspond to the definitions given in the description, for enhancing stress tolerance in plants to abiotic stress, for strengthening plant growth and/or for increasing plant yield, and selected processes for preparing the compounds mentioned above.

  使用通式（I）中的替代的异喹啉酮、异喹啉二酮、异喹啉三酮和二氢异喹啉酮或它们的相应盐，其中通式（I）中的基团对应于描述中给出的定义，用于增强植物对非生物胁迫的耐受性，增强植物生长和/或增加植物产量，并选择性地制备上述化合物的过程。
• [EN] COMPOUNDS AND METHODS FOR THE TREATMENT OF NON‑ALCOHOLIC STEATOHEPATITIS<br/>[FR] COMPOSÉS ET PROCÉDÉS DESTINÉS AU TRAITEMENT DE LA STÉATOHÉPATITE NON ALCOOLIQUE
  申请人：AVALIV THERAPEUTICS

  公开号：WO2019111225A1

  公开（公告）日：2019-06-13

  Compounds and compositions are provided having the structure of Formula (I) or a pharmaceutically acceptable salt, tautomer, or stereoisomer thereof, wherein T, T', U, U', V, W, R1, R2, R3', n, o, o', o'', and o''' are as defined herein. Such compounds are useful for treating liver diseases and abnormal liver conditions, including non-alcoholic steatohepatitis via inhibition of the lysosomal enzyme cathepsin D. Accordingly, a variety of treatment methods are hereby disclosed, including treatment of underlying conditions such as hepatic inflammation, aberrant lipid metabolism, and irregular lysosomal function.

  提供具有Formula (I)结构或其药用可接受的盐、互变异构体或立体异构体的化合物和组合物，其中T、T'、U、U'、V、W、R1、R2、R3'、n、o、o'、o''和o'''如本文所定义。这些化合物可用于治疗肝病和异常肝脏状况，包括通过抑制溶酶体酶蛋白酶D来治疗非酒精性脂肪性肝炎。因此，这里公开了各种治疗方法，包括治疗基础疾病，如肝脏炎症、异常脂质代谢和溶酶体功能异常。
• Synthesis and Electrochemical Properties of Structurally Modified Flavin Compounds
  作者：Madina Mansurova、Melissa S. Koay、Wolfgang Gärtner

  DOI：10.1002/ejoc.200800504

  日期：2008.11

  Four structurally modified flavin compounds have been synthesized and characterized for their redox potential by chemical reduction with sodium dithionite. Besides the previously reported 1- and 5-deazariboflavin, a 7,8-didemethyl derivative and an 8-isopropylriboflavin have been obtained. The synthesis of these compounds started in all cases from appropriately substituted anilines that were condensed

  已经合成了四种结构改性的黄素化合物，并通过用连二亚硫酸钠化学还原来表征它们的氧化还原电位。除了先前报道的 1- 和 5- 脱氮杂核黄素外，还获得了 7,8- 二甲基衍生物和 8-异丙基核黄素。在所有情况下，这些化合物的合成都是从适当取代的苯胺开始，该苯胺与核糖基链缩合，然后完成退火的三环结构。双去甲基和异丙基化合物的吸收最大值与核黄素相似（分别为 436 和 448 nm），而 1-去氮杂核黄素显示出红移吸收（λmax = 537 nm），而 5-去氮杂核黄素则显示出红移吸收（λmax = 400 纳米）。四种修饰的黄素化合物的中点电位 (E0') 通过电位滴定法测定，使用核黄素作为参考化合物。两种烷基改性黄素的负中点电位略低，而与参考化合物相比，两种脱氮化合物具有更多的负中点值。(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany
• BLACK DISAZO DYES, THEIR PREPARATION AND USE
  申请人：BAETTIG Kurt

  公开号：US20120090503A1

  公开（公告）日：2012-04-19

  Black disazo dyes of general formula (V) wherein A is a moiety of formula (VI) or of formula (VII) and B is a moiety of formula (VIII) or of formula (IX) and wherein M, R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , R 14 , R 15 , R 16 , R 17 , R 18 , R 19 , R 20 , R 21 , R 22 , R 23 and R 24 are as defined in the specification, are excellent black dyes for dying and printing cellulose containing materials and textile materials and, in particular, for the preparation of recording liquids for ink jet printing and for writing utensils.

  通式（V）的黑色二氮基染料，其中A是式（VI）或式（VII）的基团，B是式（VIII）或式（IX）的基团，其中M、R1、R2、R3、R4、R5、R6、R7、R8、R9、R10、R11、R12、R13、R14、R15、R16、R17、R18、R19、R20、R21、R22、R23和R24如规范中定义，对于染色和印刷含纤维素材料和纺织品材料，特别是用于制备喷墨打印记录液和书写工具，是极好的黑色染料。